Menu Search
Equities

MEI Pharma Inc

MMI0:BER

MEI Pharma Inc

Actions
  • Price (EUR)3.43
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 17 2023 07:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year MEI Pharma Inc grew revenues 19.95% from 40.70m to 48.82m while net income improved from a loss of 54.45m to a smaller loss of 31.84m.
Gross margin--
Net profit margin39.18%
Operating margin33.62%
Return on assets25.46%
Return on equity61.27%
Return on investment30.38%
More ▼

Cash flow in USDView more

In 2023, MEI Pharma Inc increased its cash reserves by 7.41%, or 1.17m. Cash Flow from Investing totalled 53.69m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 52.48m for operations while cash used for financing totalled 40.00k.
Cash flow per share3.98
Price/Cash flow per share0.7892
Book value per share7.66
Tangible book value per share7.66
More ▼

Balance sheet in USDView more

MEI Pharma Inc uses little or no debt in its capital structure.
Current ratio6.17
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.